THE FUTURE
OUR FUTURE IS AN EXCITING ONE.
The first independent clinical trials are currently underway at the prestigious University College London, which is home to one of the leading liver research departments in the world. The first results are expected by the end of 2021.
The trials will be overseen by Prof. Rajiv Jalan, a world-renowned Hepatologist at University College London and Head of the Liver Failure Laboratory at the Royal Free Hospital in London, and Dr. Yadhu Rajalingam, a Senior Consultant specialising in Critical Care Medicine and Anaesthetics at the Royal Free Hospital.
In parallel, we’ve partnered with world-leading hardware and software providers to develop wearable technologies. This will put the accurate measurement and monitoring of liver health in your hands as well as giving data to medical professionals, ensuring peak health is maintained, and any issues are spotted early. We believe prevention is better than cure.
By making global health and lifestyle data so readily available we can understand the full breadth of our product’s potential, identify additional underlying health issues and develop new treatments.
WE’RE LOOKING FOR LIKE-MINDED INVESTORS WHO SHARE OUR PASSION AND OUR AIMS.
IF THAT SOUNDS LIKE YOU, PLEASE GET IN TOUCH AT INVESTORS@EQUILIBRIUMLABS.COM.
OUR CHARITY
The liver plays a vitally important role in our overall health. Liver disease is the fifth most common cause of death in the world. And yet little is spoken about it. We aim to change that. That’s why we’re proud to partner with Livers for Life, a charity established by Dr Jalan, whose mission is to focus attention on the importance of looking after your liver, and the steps you can take to improve liver health.